Dow Chemical 2013 Annual Report Download - page 51
Download and view the complete annual report
Please find page 51 of the 2013 Dow Chemical annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41 -
42 -
43 -
44 -
45 -
46 -
47 -
48 -
49 -
50 -
51 -
52 -
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
 |
 |
29
The Dow Chemical Company and Subsidiaries
PART II, Item 6. Selected Financial Data.
SELECTED FINANCIAL DATA
In millions, except as noted (Unaudited) 2013 2012 2011 2010 2009
Summary of Operations (1)
Net sales $ 57,080 $ 56,786 $ 59,985 $ 53,674 $ 44,875
Net income from continuing operations 4,816 1,100 2,784 2,321 566
Per share of common stock (in dollars):
Net income from continuing operations per common share - basic 3.72 0.71 2.06 1.75 0.22
Net income from continuing operations per common share - diluted 3.68 0.70 2.05 1.72 0.22
Cash dividends declared per share of common stock 1.28 1.21 0.90 0.60 0.60
Book value per share of common stock 22.59 17.73 19.28 19.23 18.42
Year-end Financial Position
Total assets $ 69,501 $ 69,605 $ 69,224 $ 69,588 $ 66,018
Long-term debt 16,820 19,919 18,310 20,605 19,152
Financial Ratios
Research and development expenses as percent of net sales 3.1% 3.0% 2.7% 3.1% 3.3%
Income from continuing operations before income taxes as percent of
net sales 11.9% 2.9% 6.0% 5.2% 1.0%
Return on stockholders’ equity 19.4% 5.0% 13.1% 11.0% 2.0%
Debt as a percent of total capitalization 39.0% 48.8% 48.0% 51.3% 51.4%
(1) Adjusted to report sale of the Calcium Chloride business in 2009 as discontinued operations.